National Medical Research Center for Hematology

Recent papers from National Medical Research Center for Hematology

1. Systematic Characterization of AML Cell Lines to Support Preclinical In Vitro CAR-T ResearchCells · 2026
2. Copy-Number Alterations and Copy-Neutral Loss of Heterozygosity in Adult T-ALL: A Descriptive Study in Relation to Day +70 MRDInternational Journal of Molecular Sciences · 2026
3. Magnetite Concentration-Driven Evolution of Microstructure and Property Tuning in Alginate HydrogelsGels · 2026
4. Minimal residual disease – guided ibrutinib and venetoclax in patients with chronic lymphocytic leukaemia and complex karyotypeBritish Journal of Haematology · 2026
5. The Proteome of Bone Marrow Multipotent Mesenchymal Stromal Cells Undergoes Significant Alterations in Acute Leukemia Patients at the Onset and During TreatmentInternational Journal of Molecular Sciences · 2026
6. Following debut disasters: primary vitreoretinal lymphomaГематология и трансфузиология · 2026
7. Sclerosing Angiomatoid Nodular Transformation of Spleen and Renal Cancer Associated with Reactive Cytotoxic T-Cell Population: A Rare Case ReportClinical oncohematology · 2026
8. Features of the Intestinal and Respiratory Microbiome in Colorectal Cancer Patients in Western SiberiaMicroorganisms · 2026
9. Frequency of Non-Type I/II CALR Mutations in Patients Undergoing Molecular Diagnostics for Myeloproliferative NeoplasmsDiseases · 2026
10. A phase 3 study of olverembatinib (HQP1351) in patients with chronic-phase chronic myeloid leukemia: POLARIS-2 trial in progress.Journal of Clinical Oncology · 2026
11. Genetic Determinants of T-Cell Homeostasis in Critical Illness: An Exploratory Analysis of Immune Gene Variants and TREC DynamicsJournal of Personalized Medicine · 2026
12. A randomized, multicenter Phase II trial to compare prophylaxis of graft versus host disease with tacrolimus and mycophenolate mofetil versus ruxolitinib after post-transplant cyclophosphamide.2026
13. Crossroads of well-being: oral health, neurology, neuronutrition and healthy agingOpen Medicine · 2026
14. FCR-I/iven combination for CLL: «Cheap but fierce»Blood · 2025
15. Pola-R-CHP in previously untreated diffuse large B-cell lymphoma: Real-world data in RussiaBlood · 2025
16. Distinctive features of patients with MPN during pregnancy: Thrombotic risk, molecular drivers, and differential outcomes by subtypeBlood · 2025
17. Phenotypic spectrum and treatment outcomes in Russian gaucher disease patients: Real-world experience with biosimilar imigluceraseBlood · 2025
18. Somatic mutations in cancer-related genes in chronic myeloid leukemia patients receiving asciminibBlood · 2025
19. Long-term therapy with eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria: Two-year interim results of a prospective multicenter observational studyBlood · 2025
20. Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMTBone Marrow Transplantation · 2025